Showing 1 - 5 results of 5 for search 'Leonard Maboko', query time: 0.01s Refine Results
  1. 1
    Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania.

    Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania. by Jim Todd, Gabriele Riedner, Leonard Maboko, Michael Hoelscher, Helen A Weiss, Eligius Lyamuya, David Mabey, Mary Rusizoka, Laurent Belec, Richard Hayes

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Utility of population-based HIV impact assessments to understand the associations of stigma with the HIV treatment cascade: Analytical framework using cross-sectional evidence from Tanzania.

    Utility of population-based HIV impact assessments to understand the associations of stigma with the HIV treatment cascade: Analytical framework using cross-sectional evidence from... by Mohamed F Jalloh, Alexander Kailembo, Nicolas Schaad, Sophia A Nur, Prosper Njau, Haruka Maruyama, Kayla Lavilla, Kathy Hageman, Mbaraka Amuri, Nora Hennesy, Eunice Mmari, Mahesh Swaminathan, Leonard Maboko, George S Mgomella

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Implications of storing urinary DNA from different populations for molecular analyses.

    Implications of storing urinary DNA from different populations for molecular analyses. by Angela Cannas, Glendah Kalunga, Clare Green, Ludovica Calvo, Patrick Katemangwe, Klaus Reither, Mark D Perkins, Leonard Maboko, Michael Hoelscher, Elizabeth A Talbot, Peter Mwaba, Alimuddin I Zumla, Enrico Girardi, Jim F Huggett, TB trDNA consortium

    Published 2009-09-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial.

    Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Tri... by Agricola Joachim, Agricola Joachim, Asli Bauer, Sarah Joseph, Christof Geldmacher, Patricia J Munseri, Said Aboud, Marco Missanga, Philipp Mann, Britta Wahren, Guido Ferrari, Victoria R Polonis, Merlin L Robb, Jonathan Weber, Roger Tatoud, Leonard Maboko, Michael Hoelscher, Eligius F Lyamuya, Gunnel Biberfeld, Eric Sandström, Arne Kroidl, Muhammad Bakari, Charlotta Nilsson, Sheena McCormack

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.

    Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical tri... by Patricia J Munseri, Arne Kroidl, Charlotta Nilsson, Agricola Joachim, Christof Geldmacher, Philipp Mann, Candida Moshiro, Said Aboud, Eligius Lyamuya, Leonard Maboko, Marco Missanga, Bahati Kaluwa, Sayoki Mfinanga, Lilly Podola, Asli Bauer, Karina Godoy-Ramirez, Mary Marovich, Bernard Moss, Michael Hoelscher, Frances Gotch, Wolfgang Stöhr, Richard Stout, Sheena McCormack, Britta Wahren, Fred Mhalu, Merlin L Robb, Gunnel Biberfeld, Eric Sandström, Muhammad Bakari

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: